EP3218397
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.11.2015:
24.2.2021:
15797815.6
:
12.11.2035
:
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE
13.11.2015
24.2.2021
:
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services:
National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20852-7660, US
:
The United States Government, as represented by The Secretary of The Army:
504 Scott Street, Fort Detrick, MD 21702, US
:
Humabs Biomed S.A.:
Via Mirasole 1, 6500 Bellinzona, CH
:
Institute for Research in Biomedicine:
Via Vincenzo Vela 6, 6500 Bellinzona, CH
:
CORTI, Davide:
CH-6500 Bellinzona, CH
:
LANZAVECCHIA, Antonio:
CH-6500 Bellinzona, CH
:
TREFRY, John:
MD 210702, US
:
SULLIVAN, Nancy:
MD 20892, US
:
MULANGU, Sabue:
MD 20892, US
:
GRAHAM, Barncy:
MD 20892, US
:
MUYEMBE-TAMFUN, Jean-Jacques:
Kinshasa, CG
:
LEDGERWOOD, Julie:
Bethesda, MD 20892, US
:
STANLEY, Daphne:
Bethesda, MD 20892, US
:
201462080094 P:
14.11.2014:
US
:
201462087087 P:
3.12.2014:
US
:
US2015060733:
13.11.2015
:
C07K 16/10